Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma. (Q51830654)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 2009
edit
Language Label Description Also known as
English
Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma.
scientific article published in June 2009

    Statements

    Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit